Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/10/2025

Managing Mirtazapine-Induced Excessive Sleepiness

Assessment and Optimization Strategies

  • The American Geriatrics Society recommends confirming adequate nighttime sleep duration (7-9 hours) and maintaining a regular sleep-wake schedule to avoid sleep deprivation, which compounds medication-induced sleepiness 1
  • Rule out obstructive sleep apnea using the Epworth Sleepiness Scale, as this must be treated before attributing all sleepiness to mirtazapine 2, 1
  • Check thyroid function, complete blood count, comprehensive metabolic panel, and liver function tests to exclude metabolic causes of somnolence 2, 1
  • Assess baseline blood pressure and heart rate before considering stimulant therapy 2

Non-Pharmacological Interventions

  • Schedule two brief 15-20 minute naps daily, one around noon and another around 4:00-5:00 PM, to partially alleviate daytime sleepiness 1, 3
  • Increase daytime light exposure and physical/social activities, particularly important if cognitive impairment coexists 2, 1
  • Avoid heavy meals throughout the day and eliminate alcohol use, as both worsen medication-induced sedation 1

Pharmacological Countermeasures

  • Start modafinil 100 mg once upon awakening as the first-line pharmacologic treatment for mirtazapine-induced sedation, as recommended by the American Geriatrics Society 2, 1, 3
  • Increase modafinil by 100 mg increments at weekly intervals as necessary, with typical effective doses ranging 200-400 mg daily 2, 1, 3
  • Common adverse effects of modafinil include nausea, headaches, and nervousness 1
  • Monitor blood pressure, heart rate, and cardiac rhythm when initiating or adjusting modafinil doses, as hypertension, palpitations, and arrhythmias can occur 2, 1
  • The American College of Cardiology recommends adding judicious caffeine use (maximum <300 mg daily) with the last dose no later than 4:00 PM as an adjunctive measure 2, 1

Critical Safety Considerations

  • Do NOT add benzodiazepines, as they cause decreased cognitive performance in elderly patients or those with cognitive impairment, according to the National Comprehensive Cancer Network 2, 1
  • Avoid melatonin in older patients due to poor FDA regulation and inconsistent preparation quality 2
  • Do not use zolpidem without extreme caution due to next-morning impairment risk, especially in elderly patients 2

Monitoring Requirements

  • Reassess daytime alertness and functional status at each visit using the Epworth Sleepiness Scale to track treatment response 2, 1
  • Assess for behavioral manifestations, including irritability or psychosis, during stimulant therapy 2, 1
  • More frequent follow-up visits are necessary when starting medications or adjusting doses 1

When to Refer

  • Refer to a sleep specialist if sleepiness persists despite dose optimization and behavioral interventions 1, 3
  • Refer to a sleep specialist if underlying primary sleep disorders are suspected after initial workup 2, 1
  • Refer to a sleep specialist if the patient is unresponsive to initial or subsequent therapy 2

Important Context About Mirtazapine

  • The American Heart Association notes that mirtazapine "may be used for sleep" and offers "additional benefits, including appetite stimulation" 4

REFERENCES

1

Managing SNRI-Induced Sleepiness [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Managing Excessive Somnolence in Patients with Alzheimer's Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Managing Sleepiness from Valproate Therapy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025